ADHD and Addiction: Why They Co-Occur and How Treatment Works

ADHD and Addiction: Why They Co-Occur and How Treatment Works

ADHD and Addiction in Orange County

Tried to Get Sober and Your Brain Still Will Not Cooperate?

Untreated ADHD is one of the most commonly missed reasons that addiction treatment does not stick. Broadway Treatment Center connects you with Orange County programs that assess and treat both conditions together, and we verify your benefits before any commitment.

Call Now: (714) 400-2048

If someone is in immediate danger, call 911. If you or someone you love is in emotional crisis or thinking about suicide, call or text 988 to reach the Suicide and Crisis Lifeline, available 24 hours a day. Adults with untreated ADHD and a substance use disorder carry a meaningfully elevated risk of impulsive self-harm, so do not wait for the feeling to pass on its own. For confidential, 24/7 help finding a treatment program in Orange County, call (714) 400-2048.

Attention-deficit/hyperactivity disorder and substance use disorder appear together far more often than chance would predict, and the overlap is not a coincidence of bad luck or weak character. The two conditions share brain circuitry, share a core problem with impulse control and delayed reward, and feed each other in ways that make each one harder to treat alone. When ADHD goes unrecognized in someone seeking addiction treatment, the treatment itself often fails for reasons nobody in the room correctly identifies.

This guide explains what ADHD is, why it travels with addiction, how each substance class interacts with an ADHD brain, why the diagnosis is genuinely difficult to make in someone who is actively using, and what integrated treatment looks like when both conditions are addressed at the same time. It is written for the person who has been through treatment before and relapsed, for the partner who cannot understand why promises keep evaporating, and for the parent watching an adult child cycle through programs that never quite fit.

An important disclosure before you read further: Broadway Treatment Center is a treatment placement and referral service, not a treatment facility. We do not own, operate, or staff a clinic, and nothing on this page is a diagnosis or a prescription. What we do is help people in Orange County and across California understand their options, verify insurance benefits, and coordinate admission with a network of verified, licensed providers. Every clinical decision described below belongs to a licensed evaluating clinician who has actually met the person being treated.

ADHD and Addiction: The Short Answer

ADHD raises the risk of developing a substance use disorder, and substance use disorder makes ADHD symptoms worse and harder to see clearly. Research reviews of adults in addiction treatment consistently find ADHD substantially over-represented compared with the general adult population, with commonly cited estimates clustering around one in four, though the figure varies widely depending on the setting, the screening instrument, and how carefully childhood history is documented. The practical takeaway does not depend on the exact number: if you are in treatment for a substance use disorder and you have a lifelong history of inattention, restlessness, and impulsivity that predates your drug use, that history deserves a formal evaluation.

Treating one condition and ignoring the other rarely works. Getting sober does not repair the executive-function deficits that made structure feel impossible in the first place, and treating ADHD in someone who is still using daily is like tuning an engine while the car is on fire. The approach with the best support is integrated care, where the same clinical team addresses both conditions on a coordinated plan. You can read more about that model on our overview of co-occurring disorders and addiction and on the dual diagnosis treatment pillar page.

What ADHD Actually Is

ADHD is a neurodevelopmental disorder, which means it originates in how the brain develops rather than appearing suddenly in adulthood as a reaction to stress. In the DSM-5, the diagnosis requires a persistent pattern of inattention, hyperactivity, or impulsivity that interferes with functioning or development, with several symptoms present before age 12, symptoms occurring in two or more settings such as home and work or school, and clear evidence that the symptoms reduce the quality of social, academic, or occupational functioning.

That age-12 requirement matters enormously in addiction medicine, because it is the single most useful line between true ADHD and the attention problems that substances themselves create. Someone whose concentration collapsed at 29 after five years of heavy stimulant use has an attention problem, but it is not ADHD. Someone who was the kid who lost three backpacks a year, could not finish a worksheet, and got moved to the front row every September has a developmental history that points somewhere different.

The Three Presentations

Clinicians describe ADHD in three presentations rather than three separate disorders, and a person’s presentation can shift across the lifespan.

  • Predominantly inattentive presentation. Difficulty sustaining attention on non-preferred tasks, careless errors, losing things, forgetfulness in daily activities, appearing not to listen, avoiding tasks that require sustained mental effort. This presentation is the one most often missed, particularly in women and in adults who learned to compensate with intelligence or rigid external structure.
  • Predominantly hyperactive-impulsive presentation. Restlessness, fidgeting, difficulty remaining seated, talking excessively, interrupting, difficulty waiting a turn, acting without considering consequences. In adults, visible hyperactivity often softens into a persistent internal restlessness that people describe as feeling driven by a motor they cannot switch off.
  • Combined presentation. Enough symptoms from both domains to meet criteria for each. This is the most common presentation in clinical samples and carries the highest association with substance use problems, largely because impulsivity is the ingredient that converts risk into behavior.

Adults with ADHD also report a cluster of features that are not formal diagnostic criteria but show up constantly in clinical interviews: emotional dysregulation and short fuse, rejection sensitivity, chronic lateness, difficulty starting tasks even when the consequences of not starting are severe, and hyperfocus on stimulating activities that coexists confusingly with an inability to focus on anything routine. That last pairing is why so many adults dismiss the possibility of ADHD. They can concentrate for nine hours on something interesting, so they assume attention is not the problem. Attention is not the problem. Regulation of attention is.

What ADHD Is Not

ADHD is not a deficit of intelligence, effort, or moral fiber, and it is not a modern invention. It is also not the same thing as being distracted by a stressful life, being sleep deprived, or being in early sobriety. Each of those can produce inattention that looks superficially identical. The distinction is developmental history and pervasiveness, which is exactly why a careful evaluation involves more than a five-minute checklist. Understanding the difference between a symptom and a disorder is the same discipline required to separate physical dependence from addiction, and it deserves the same care.

Why ADHD and Substance Use Disorder Show Up Together

There is no single mechanism. The association is best understood as several overlapping pathways that reinforce one another, which is also why interventions that address only one pathway tend to underperform.

Shared Brain Circuitry

ADHD and addiction both involve dopaminergic and noradrenergic signaling in circuits connecting the prefrontal cortex to the striatum. The prefrontal cortex handles planning, working memory, inhibition of prepotent responses, and the ability to hold a future consequence in mind while a present temptation is shouting. The striatum handles reward valuation and habit formation. In ADHD, that prefrontal-striatal loop is underpowered for tasks with delayed or abstract payoffs. In addiction, the same loop is progressively hijacked so that drug-related cues acquire outsized motivational pull while everything else fades.

The result is a brain that starts with a weakened brake and then gets handed a substance that both loosens the brake further and installs a very loud accelerator. The National Institute on Drug Abuse discusses this comorbidity pattern across mental illness and substance use in its research on comorbidity between substance use disorders and other mental illnesses.

Impulsivity and Delay Discounting

Delay discounting is the measurable tendency to devalue a reward as the wait for it grows longer. Everyone discounts the future to some degree. People with ADHD discount it steeply, and so do people with substance use disorders. Steep discounting is not a philosophy about living in the moment. It is a quantifiable feature of decision-making that makes “one drink now” structurally more compelling than “feeling functional tomorrow morning,” even when the person can articulate perfectly well which choice is better.

This is the single most clinically useful thing for families to understand. When a person with ADHD relapses two days after a heartfelt commitment, the commitment was real. What failed was the machinery that carries a commitment across a gap in time while a strong immediate signal is competing for the same channel. Treatment that adds external structure, immediate reinforcement, and shortened feedback loops is not condescending. It is aimed directly at the deficit.

Self-Medication

Many adults with undiagnosed ADHD describe their first meaningful experience of relief in terms that a clinician recognizes immediately. Alcohol quiets the mental noise. Cannabis makes the restlessness tolerable enough to sit through a movie or fall asleep. Nicotine sharpens focus in short bursts. Cocaine or methamphetamine, at least at first, delivers the organized, motivated, on-task state the person has been chasing their entire life. That first experience is often described not as getting high but as finally feeling normal.

Self-medication is a real and important pathway, but it should not be romanticized. The relief is short-lived, the dose required climbs, and the substance eventually degrades the very functions it was recruited to fix. Someone who started using stimulants to get through nursing school ends up unable to hold the job the degree was for. The mechanism is worth naming out loud in treatment, though, because it converts a story of moral failure into a story of an untreated condition, and that reframing is often what makes a person willing to engage at all.

Earlier First Use and Faster Escalation

Adolescents with ADHD tend to begin using substances earlier than their peers, and earlier onset of use is one of the more reliable predictors of developing a substance use disorder later. Earlier use means more exposure during a period when the prefrontal cortex is still maturing, and it means more years for a habit to consolidate. Impulsivity also increases the raw number of opportunities taken: more parties attended, more offers accepted, more experiments run without a pause to consider the downside.

Overlapping Risk Factors and Accumulated Consequences

ADHD frequently coexists with conduct problems in childhood, and childhood conduct disorder is itself a strong predictor of adult substance use disorder. Some of the association between ADHD and addiction runs through that pathway rather than through ADHD directly. Separately, ADHD produces a long accumulation of academic underperformance, job instability, financial chaos, relationship conflict, and traffic and legal problems. Each of those is a stressor, and chronic stress is independently associated with substance use. By the time an adult with untreated ADHD reaches 30, the disorder has often built the exact life circumstances that make heavy drinking or drug use feel reasonable.

The same layering shows up with other co-occurring conditions. Trauma exposure, depression, and anxiety all cluster in this population, and each one changes the treatment plan. We cover those interactions separately in our guides to PTSD and substance use disorder, depression and substance use disorder, and anxiety disorders and substance use treatment.

Substance by Substance: What an ADHD Brain Tends to Reach For

ADHD does not point toward one specific drug. It raises risk across the board, but the reasons people give for choosing a particular substance are consistent enough to be clinically useful. Each class also carries its own withdrawal profile and its own danger gradient, and those differences drive the level of care that a safe plan requires.

Alcohol

Alcohol is the most common substance involved when ADHD and substance use disorder co-occur, partly because it is legal and ubiquitous and partly because sedation is genuinely effective at quieting internal restlessness in the short term. The problem is that alcohol impairs working memory and inhibition, the two functions ADHD has already compromised, so intoxication amplifies exactly the deficits that cause trouble. Alcohol also fragments sleep in the second half of the night, and poor sleep worsens ADHD symptoms the next day, which increases the pull toward another drink.

Alcohol withdrawal is one of the two substance classes that can be fatal without medical management. Early symptoms typically begin 6 to 24 hours after the last drink with tremor, sweating, anxiety, nausea, and elevated heart rate and blood pressure. The seizure window is roughly 12 to 48 hours. Delirium tremens, the most dangerous manifestation, usually emerges 48 to 96 hours in and can involve profound confusion, hallucinations, severe autonomic instability, and death when untreated. Clinicians track severity with the Clinical Institute Withdrawal Assessment for Alcohol, revised, commonly abbreviated CIWA-Ar, and treat with benzodiazepines on symptom-triggered or fixed-schedule protocols, along with thiamine supplementation. Our full breakdown is on the alcohol withdrawal symptoms and timeline page. Medically supervised detox is not optional for significant alcohol dependence.

Cannabis

Cannabis use is strongly associated with ADHD, and the reasons people report are almost always the same: it slows down racing thoughts, makes physical restlessness bearable, and helps with sleep onset. The trade-off is that cannabis acutely impairs working memory, sustained attention, and motivation, which are the exact domains ADHD already taxes. Regular heavy use also tends to blunt the drive to build the organizational scaffolding that ADHD management depends on.

Cannabis withdrawal is not medically dangerous, but it is real and it is frequently underestimated. Irritability, anxiety, sleep disturbance with vivid dreams, decreased appetite, and restlessness typically peak in the first week and taper over two to three weeks. For someone with ADHD, that window is particularly rough because the withdrawal symptoms and the untreated baseline symptoms stack on top of each other. More detail is on our cannabis use disorder page.

Stimulants: Cocaine, Methamphetamine, and Misused Prescription Stimulants

This is the most clinically loaded category, because the pharmacology that makes prescription stimulants therapeutic at controlled doses is the same pharmacology that makes illicit stimulants destructive at escalating ones. Someone with untreated ADHD who tries cocaine or methamphetamine may experience it as clarity rather than euphoria, and that experience is dangerously reinforcing. Prescription stimulants obtained without a prescription occupy the same space, often starting as academic or occupational performance aids.

Stimulant withdrawal is psychiatric rather than pharmacologically dangerous in the way alcohol and benzodiazepine withdrawal are. The crash brings profound fatigue, hypersomnia followed by fragmented sleep, increased appetite, anhedonia, depressed mood, and cravings, with suicidality a genuine risk during the first one to two weeks. There is no CIWA-Ar or COWS equivalent for stimulants and no FDA-approved medication for stimulant use disorder. The best-supported intervention is contingency management, a behavioral approach that provides immediate tangible reinforcement for verified abstinence, which is notably well matched to the delay-discounting problem described earlier.

Heavy stimulant use also carries a risk of stimulant-induced psychosis, and sleep deprivation is an independent driver of that. Timelines for the two most common illicit stimulants are on our methamphetamine withdrawal timeline and cocaine withdrawal symptoms pages, and our guide to prescription stimulant addiction treatment covers the Adderall and Ritalin side of this specifically.

Nicotine

Nicotine use, including vaping, is markedly more common among people with ADHD than in the general population. Nicotine produces short-lived improvements in attention and working memory, and the delivery is fast, repeatable, and socially permitted, which makes it a nearly perfect fit for a brain seeking frequent small hits of regulation. Nicotine dependence is often left unaddressed in addiction treatment, but it is worth naming in the treatment plan rather than deferring indefinitely.

Opioids

Opioids do not map onto ADHD symptoms the way stimulants and alcohol do, but impulsivity raises exposure risk, and ADHD is over-represented in opioid treatment populations. In practice, the pathway often runs through injury, a prescription, and a difficulty with self-limiting use rather than through deliberate self-medication of attention symptoms.

Opioid withdrawal is intensely uncomfortable but not directly life-threatening for an otherwise stable adult, with dehydration from vomiting and diarrhea being the main medical concern. Clinicians measure it with the Clinical Opiate Withdrawal Scale, abbreviated COWS. The far greater danger is the post-detox overdose window: tolerance drops quickly during abstinence, and a return to a previously routine dose can be fatal, especially given how thoroughly fentanyl now contaminates the Southern California supply. Buprenorphine, methadone, and extended-release naltrexone are the medications with the strongest evidence base, and the American Society of Addiction Medicine endorses medication initiation as a standard of care rather than an optional add-on. See our medication-assisted treatment overview.

Benzodiazepines and Other Sedatives

Benzodiazepines are sometimes prescribed for the anxiety and insomnia that accompany untreated ADHD, and they can become a dependence problem on their own. Like alcohol, benzodiazepine withdrawal can produce seizures and is potentially fatal when a physically dependent person stops abruptly. Management involves a supervised taper, often by converting to a longer-acting agent, and it can take weeks to months rather than days. Nobody who is physically dependent on benzodiazepines should stop without medical supervision. Detox planning across all of these classes is covered on our Orange County medical detox pillar page.

ADHD Changes the Treatment Plan, and the Substance Changes the Safety Plan

Which substance is involved, how physically dependent the body has become, whether ADHD has ever been formally evaluated, and what other conditions are in play all determine what a safe first step looks like. A clinical assessment can help determine the safest next step, and we verify your benefits before any commitment.

Why ADHD Is So Hard to Diagnose in Someone Who Is Using

Diagnosing ADHD in an active substance use disorder is one of the genuinely difficult problems in behavioral health, and it is difficult in both directions. Miss the ADHD and treatment keeps failing for invisible reasons. Diagnose ADHD too readily and a person receives a controlled stimulant prescription they may not need and may not be able to manage safely. Good clinicians take the problem seriously and refuse to shortcut it.

Substances and Withdrawal Mimic ADHD Almost Perfectly

Chronic heavy use of nearly anything produces inattention, disorganization, forgetfulness, and irritability. Stimulant withdrawal produces poor concentration and restlessness. Alcohol produces cognitive impairment that lingers well past the acute phase. Cannabis blunts working memory and motivation. Post-acute withdrawal, the extended period of mood instability, cognitive fog, and sleep disruption that follows acute detox for many substances, looks like textbook inattentive ADHD for weeks to months. Layer chronic sleep deprivation on top, since insomnia is nearly universal in early recovery, and the picture is indistinguishable on a symptom checklist alone.

What Clinicians Look For Instead

Because a checklist of current symptoms cannot separate these possibilities, a credible ADHD evaluation in an addiction setting relies on converging evidence:

  • Developmental history. Documented or clearly recalled symptoms before age 12, and ideally a description of functional impairment in elementary school. This is the anchor of the whole assessment.
  • Collateral informants. A parent, older sibling, long-term partner, or anyone who knew the person as a child. Adult self-report of childhood symptoms is unreliable in both directions, and a second source materially improves accuracy.
  • Records. Old report cards, teacher comments, prior psychoeducational testing, individualized education plans, and any earlier evaluation. A comment like “bright but does not apply himself” repeated across four school years is meaningful data.
  • Standardized instruments. Screening tools such as the Adult ADHD Self-Report Scale, commonly called the ASRS, and structured diagnostic interviews designed for adult ADHD. Screeners flag people for further evaluation; they do not diagnose on their own, and no clinician should treat a positive screen as a conclusion.
  • A careful substance use timeline. Mapping when symptoms appeared against when use began and escalated. If the attention problems arrived four years after the drinking did, the developmental criterion is not met.
  • Symptom persistence across periods of abstinence. Any prior stretch of sobriety, even an involuntary one, is informative. Symptoms that persisted through six clean months in a structured setting point toward an independent disorder.

The Abstinence Question

Clinicians have historically preferred to wait through a period of abstinence, often cited as several weeks to a few months, before making a formal ADHD diagnosis, so that acute and post-acute substance effects have time to clear. That preference is reasonable and it remains common practice. It is also increasingly balanced against a practical reality: for some people, untreated ADHD is precisely what makes it impossible to stay abstinent long enough to satisfy the waiting period. Modern integrated practice tends to begin the evaluation early, gather developmental history and collateral information while the person is still stabilizing, defer the final diagnostic conclusion and any decision about controlled medication until the picture is clearer, and treat the ADHD-related functional problems with behavioral strategies in the meantime. The right balance is a clinical judgment made by the evaluating prescriber, not a rule that can be set in advance from a web page.

FeaturePoints toward ADHDPoints toward substance-related cognitive impairment
Age at onsetSeveral symptoms clearly present before age 12Onset after substance use began or escalated
Course over timeLifelong and relatively stable, worse under demandFluctuates with use, intoxication, and withdrawal
Settings affectedTwo or more settings since childhoodOften tied to periods of heaviest use
Response to abstinencePersists after weeks to months cleanImproves substantially with sustained abstinence
Collateral reportFamily recalls childhood symptoms independentlyFamily dates the change to the using years
School recordsDocumented attention or behavior concernsUnremarkable academic history until later
Sleep contributionSymptoms present even in well-rested periodsTracks closely with insomnia and sleep debt

Sleep deserves its own mention here, because it is the most common confound and the most fixable one. Insomnia in early recovery can produce daytime inattention severe enough to look like ADHD on any rating scale, and it is treatable. Our guide to sleep problems in early recovery covers what to expect and what actually helps.

What Else Gets Confused With ADHD

A thorough evaluation rules in ADHD and rules out or accounts for a list of conditions that overlap substantially. Each of these can produce inattention, restlessness, or impulsivity, and several of them commonly coexist with ADHD rather than replacing it as an explanation.

  • Major depressive disorder. Concentration difficulty is a formal diagnostic criterion for depression. The distinguishing features are episodic course, pervasive loss of interest, and mood symptoms that predate the attention complaints.
  • Anxiety disorders. Worry consumes working memory and produces restlessness that looks like hyperactivity. Someone can have both, and treating only one leaves obvious residual impairment.
  • PTSD and complex trauma. Hypervigilance, concentration problems, irritability, and sleep disruption overlap heavily with ADHD, and childhood trauma can produce a presentation that mimics it closely.
  • Bipolar disorder. Distractibility, increased goal-directed activity, and impulsivity appear in both. The distinguishing feature is episodicity: bipolar symptoms come in discrete episodes with a change from baseline, while ADHD is a stable trait-like pattern.
  • Sleep disorders. Obstructive sleep apnea, restless legs syndrome, and chronic insomnia all produce daytime inattention. Screening for these is inexpensive and frequently skipped.
  • Post-acute withdrawal. The extended cognitive and mood disturbance after acute detox can persist for months and mimic inattentive ADHD closely.
  • Medical contributors. Thyroid dysfunction, anemia, nutritional deficiencies including thiamine depletion in heavy drinkers, head injury, and chronic pain all affect attention and are worth ruling out.
  • Learning disorders. Dyslexia and related learning differences produce avoidance of academic tasks that can be mistaken for inattention.

How Integrated Treatment Works

The organizing principle is simple to state and harder to deliver: both conditions get treated at the same time, by a team that talks to itself, on one coordinated plan. The Substance Abuse and Mental Health Services Administration’s treatment protocol on substance use disorder treatment for people with co-occurring disorders is the standard reference for how this is supposed to work in practice.

Sequential, Parallel, and Integrated Care

ModelHow it worksTypical failure mode
SequentialTreat the substance use disorder first, then address ADHD once the person is stable and abstinentThe untreated ADHD undermines the abstinence the model requires before it will address the ADHD
ParallelBoth conditions treated at the same time but by separate providers who do not routinely communicateConflicting advice, medication decisions made without addiction context, the person carries the coordination burden
IntegratedOne team, one treatment plan, addiction and psychiatric care coordinated with shared documentationHarder to find and requires programs genuinely staffed for it rather than programs that use the label

When we help someone evaluate programs, the integration question is one of the specific things worth asking about directly: whether a prescriber and the counseling team are actually on the same treatment plan, whether the program will accept and continue an existing ADHD medication, and how the program approaches controlled-substance prescribing in people with a substance use history. Programs vary considerably, and the honest answer is that some will not prescribe stimulants at all. Knowing that before admission rather than after matters. Our guide to how to choose a rehab center covers the broader version of this question.

Behavioral Treatment That Fits an ADHD Brain

Standard addiction counseling assumes a set of capacities that ADHD partly removes: remembering appointments without prompts, completing homework between sessions, tolerating unstructured time, and sustaining motivation across long gaps between effort and reward. Programs that get good outcomes with this population adapt rather than assume.

  • Cognitive behavioral therapy adapted for adult ADHD. Structured skills work on planning, task initiation, prioritization, time estimation, and managing distractibility, combined with cognitive work on the demoralization and self-criticism that decades of underperformance leave behind.
  • Contingency management. Immediate, tangible reinforcement for verified abstinence and for attendance. This has the strongest evidence base for stimulant use disorder generally, and it is mechanistically well suited to steep delay discounting because it collapses the gap between behavior and reward.
  • Externalized structure. Written plans, visible calendars, phone reminders, pill organizers, single-location storage for essentials, and accountability check-ins. This is not a lack of willpower workaround. It is the standard of care for a working-memory deficit.
  • Motivational interviewing. Useful throughout, and especially in the early phase where ambivalence is high and confrontational approaches tend to backfire with people who already carry a heavy load of shame.
  • Shorter sessions, more often. Two 30-minute contacts frequently outperform one 60-minute session for someone whose attention fades and whose week is long.
  • Skills for emotional dysregulation. Dialectical behavior therapy distress-tolerance skills address the short fuse and rejection sensitivity that drive a meaningful share of impulsive use episodes.

Our overview of the types of therapy used in addiction treatment describes these modalities in more depth.

Medication: What Prescribers Weigh

Everything in this section is prescriber territory. It is included so that you can have an informed conversation with a licensed clinician, not so that you can decide in advance what you should be taking. Broadway Treatment Center does not prescribe, recommend, or supply medication.

The central tension is straightforward. Stimulant medications are the most effective treatment for ADHD in the general population, and they are also controlled substances with real misuse and diversion liability in a person with a substance use history. Non-stimulant options carry essentially no misuse liability but are generally less effective on average and take longer to work. Prescribers weigh the severity of the ADHD, the substance involved, how much recovery time and structure the person has, whether use is currently active, and what monitoring is realistically available.

ConsiderationNon-stimulant optionsStimulant options
ExamplesAtomoxetine, viloxazine, guanfacine extended-release, clonidine extended-release, bupropion used off-labelMethylphenidate formulations and amphetamine formulations, including the prodrug lisdexamfetamine
Controlled substanceNoYes, Schedule II in the United States
Misuse and diversion liabilityMinimalReal, and lower with extended-release and prodrug formulations than with immediate-release
Onset of benefitWeeks to reach full effectSame day for immediate effects
Average effect size for ADHDGenerally smallerGenerally larger
Common first choice in active or recent substance useFrequently preferred as a starting pointConsidered case by case with added safeguards
Typical safeguards when usedStandard follow-upSingle prescriber, prescription drug monitoring program checks, limited quantities, observed or supervised dispensing, urine drug testing, involvement of the treatment team

Two points deserve emphasis because they are commonly misunderstood. First, being in recovery does not automatically disqualify someone from ever receiving stimulant medication; it changes the risk calculation and the monitoring requirements, and that decision belongs to a prescriber who knows the full history. Second, treating ADHD is not a treatment for addiction. Medication may improve the functional capacity that makes recovery work sustainable, but it does not remove cravings, repair relationships, or substitute for the behavioral work.

Medications for the Substance Use Disorder Itself

ADHD treatment runs alongside, not instead of, whatever medication the substance use disorder itself calls for. Buprenorphine, methadone, and extended-release naltrexone are established options for opioid use disorder. Naltrexone and acamprosate are the primary options for alcohol use disorder, with disulfiram used in specific circumstances. There is no FDA-approved medication for stimulant or cannabis use disorder, which is why behavioral approaches carry more of the load in those cases. SAMHSA maintains a plain-language overview of medications for substance use disorders.

ADHD During Detox and Withdrawal Management

Detox is a distinct phase with its own risks, and ADHD changes how it tends to go. The medical protocol is driven by the substance, not by the ADHD: CIWA-Ar-guided benzodiazepine treatment and thiamine for alcohol, COWS-guided buprenorphine or methadone initiation and comfort medications such as clonidine, ondansetron, and loperamide for opioids, a slow supervised taper for benzodiazepines, and supportive care with close psychiatric monitoring for stimulants.

What ADHD adds is a tolerance problem rather than a pharmacologic one. Detox involves waiting, repetition, paperwork, unstructured hours, and rules, which is close to a worst-case environment for someone with poor frustration tolerance and high novelty seeking. The practical consequence is elevated risk of leaving against medical advice partway through, which is dangerous during alcohol or benzodiazepine withdrawal and raises overdose risk after opioid detox because tolerance has already fallen. Programs that anticipate this build in more frequent staff contact, movement, and concrete short-horizon goals rather than treating restlessness as noncompliance. If a prior detox attempt ended with someone walking out on day two, that is worth telling the intake team up front, because it changes how the stay is set up. What comes next after that stage is covered on our levels of care in addiction treatment page.

Choosing a Level of Care

Level of care is determined by withdrawal risk, medical and psychiatric stability, the strength of the home environment, and prior treatment history, not by preference alone. For co-occurring ADHD specifically, the amount of external structure a setting provides is a real clinical variable rather than a lifestyle question.

FactorResidential or inpatientOutpatient, PHP, or IOP
External structure providedHigh, the schedule is built for youLow to moderate, you build the rest of the day
Best fit whenWithdrawal risk is significant, the home environment is unsafe or chaotic, prior outpatient attempts have failedWithdrawal risk is low, home is stable and supportive, work or caregiving must continue
Medication supervisionObserved dosing and daily monitoringSelf-managed between visits, with periodic checks
Psychiatric accessTypically on-site and frequentScheduled appointments, often less frequent
Real-world practiceLimited during the stayContinuous, skills tested immediately
Common ADHD-specific riskRestlessness and boredom, early departureMissed appointments, unstructured hours, drift

Neither column is superior in the abstract. Many people step down through both, and stepping down too fast is a common and preventable relapse trigger. Details are on our residential treatment and outpatient rehab in Orange County pages.

Early Recovery With an ADHD Brain

The first year of recovery asks for exactly the skills ADHD compromises, which is why the standard advice needs adjustment rather than repetition at higher volume.

Structure Without Rigidity

Unstructured time is the highest-risk time. A predictable weekly skeleton of appointments, meetings, work, exercise, and sleep and wake times does more than willpower does, because it removes the number of decisions that have to be made under pressure. The skeleton should be written down somewhere visible, not held in memory, and it should have enough flexibility inside it that a single missed item does not collapse the whole structure. Perfectionist all-or-nothing scheduling fails predictably in this population.

Boredom, Novelty, and Relapse Risk

Boredom is not a trivial complaint for someone with ADHD. It is an aversive state with real physiological weight, and understimulation is one of the most reliable relapse triggers in this group. Recovery plans that consist entirely of removing things tend to fail. Plans that deliberately add stimulating, legal, structured activity, whether that is physical training, music, competitive hobbies, skilled trades, or anything with fast feedback and visible progress, tend to hold. Our guides to managing cravings in recovery and relapse prevention planning go deeper on building that plan.

Sleep

ADHD and early recovery both disrupt sleep, and sleep loss worsens attention, emotional regulation, and impulse control the next day. This is one of the highest-yield targets in the first months, and cognitive behavioral therapy for insomnia is the first-line approach rather than a sedative, particularly given that many sedatives carry their own dependence liability.

Medication Adherence

There is a cruel irony in asking a person with a memory and organization disorder to take a daily medication that improves memory and organization. Missed doses are a predictable feature, not a character flaw. Pill organizers, phone alarms, pairing the dose with an already automatic daily action, and a partner or family member who quietly checks all work better than resolve does.

Peer Support That Actually Fits

Some people with ADHD struggle with long meetings and unstructured sharing formats, and conclude that peer support is not for them. Often the format is the problem rather than the concept. Shorter meetings, discussion-based rather than lecture-based formats, service commitments that provide a role and a reason to arrive on time, and online options for the days when getting out of the house will not happen all improve attendance meaningfully.

For Partners, Parents, and Families

Families living with this combination usually arrive exhausted and holding a specific belief: that the person could do better if they simply cared more. Broken promises, missed commitments, unpaid bills, and forgotten obligations read as indifference. Understanding the delay-discounting and working-memory mechanisms does not excuse harm, and it does not obligate anyone to stay in a relationship that has become unsafe. What it does is redirect the response from arguing about motivation, which never works, toward supporting structure, which sometimes does.

  • Be concrete and short. “The appointment is Thursday at 2, and I put it in your phone” beats a conversation about responsibility.
  • Separate the disorder from the behavior. ADHD explains why something is hard. It does not make lying about drug use acceptable, and both things can be true at once.
  • Do not manage the medication as a control mechanism. Support adherence if that role is welcome; do not become the enforcement arm of a prescription.
  • Get your own support. Family therapy, Al-Anon, and similar resources exist because living with this is genuinely hard and the load is real.
  • Bring the childhood history to the evaluation. A parent who can describe what second grade looked like may be the most valuable piece of diagnostic information available.

If you are not sure how to start the conversation at all, our guides on how to help an addicted loved one and how addiction affects the family may help.

How to Get Help in Orange County

Broadway Treatment Center is based in Huntington Beach and works with programs across Orange County, including providers serving Newport Beach, Irvine, Santa Ana, Anaheim, Costa Mesa, Fountain Valley, Garden Grove, Westminster, and Buena Park. Here is what the process looks like.

  1. Call (714) 400-2048. The line is answered 24 hours a day. The first conversation is confidential and is about understanding the situation, not committing to anything.
  2. Describe both halves honestly. Which substances, how much, how recently, and whether there is any history of seizures or complicated withdrawal. Then the ADHD side: whether it was ever diagnosed, whether medication was ever prescribed, and what childhood looked like. Both halves change the recommendation.
  3. We verify your benefits. We contact the insurer and find out what is actually covered before anyone commits to anything. Coverage is verified, never guaranteed in advance, and we tell you what we find either way. You can start that at insurance verification.
  4. We match to programs that genuinely handle dual diagnosis. That means asking each program directly about psychiatric staffing, whether they will continue an existing ADHD medication, and how they approach controlled-substance prescribing in people with a substance use history. None of these programs belong to Broadway Treatment Center; they are independent licensed providers in our referral network.
  5. A licensed clinician completes the assessment. The evaluating clinician at the admitting program determines the level of care and the treatment plan. Admission always depends on that assessment, on bed availability, and on insurance authorization.
  6. We coordinate admission. Timing, transportation, what to bring, and the handoff of any current prescriptions to the admitting program’s medical team.
  7. Plan the step down before you need it. Residential to PHP or IOP to outpatient to ongoing support. Continuity is where ADHD-related drop-off happens most often, so the next appointment should be booked before the current stage ends. See aftercare support.

If you prefer not to call, you can reach us through our contact page.

Treating One Condition Is Half a Plan

Stabilization is the beginning, not the finish line. Whether the next step is detox, residential care, or an intensive outpatient schedule that leaves room for work, the plan should address the ADHD and the substance use disorder on the same page. We help you find programs staffed to do both.

Explore Dual Diagnosis Treatment

The Bottom Line

If you have been through addiction treatment more than once and it has not held, an untreated attention disorder is one of the explanations worth ruling out before concluding that treatment does not work for you. ADHD and substance use disorder share circuitry, share a specific problem with valuing the future against the present, and each makes the other harder to see and harder to treat. Neither one is a character defect, and neither one resolves on its own.

The evaluation is difficult, which is an argument for doing it carefully rather than for skipping it. The treatment is available, and integrated care that addresses both conditions on one plan gives people a materially better chance than treating either one alone. That is a realistic statement about probability, not a promise about outcomes, and any program that promises more than that is telling you something it cannot know.

Call 911 immediately for a suspected overdose, a seizure, chest pain, or any situation where someone’s safety is in immediate danger. Call or text 988 for the Suicide and Crisis Lifeline, available 24 hours a day, if you or someone you love is in emotional crisis or having thoughts of suicide. For confidential help finding an Orange County treatment program that addresses ADHD and substance use together, call Broadway Treatment Center at (714) 400-2048, any hour, any day.

Frequently Asked Questions About ADHD and Addiction

Does ADHD cause addiction?

ADHD does not cause addiction directly, but it raises the risk substantially. The connection runs through shared brain circuitry involving dopamine signaling, through impulsivity and a steep tendency to discount delayed rewards, through self-medication of untreated symptoms, and through earlier first use during adolescence. Most people with ADHD never develop a substance use disorder, and many people with substance use disorders do not have ADHD.

How common is ADHD among people in addiction treatment?

Research reviews consistently find ADHD substantially over-represented in adult addiction treatment populations compared with the general adult population, with commonly cited estimates in the range of roughly one in four. Estimates vary widely depending on the treatment setting, the screening instrument used, and how thoroughly childhood history is documented, so the figure should be treated as an indication of scale rather than a precise number.

Can ADHD be diagnosed while someone is still using?

It can be evaluated, and the evaluation often begins during active use or early stabilization, but a confident diagnosis is harder because substances and withdrawal produce symptoms that closely mimic ADHD. Many clinicians prefer to gather developmental history and collateral information early while deferring the final diagnostic conclusion until after a period of abstinence. The right timing is a clinical judgment made by the evaluating prescriber.

How long should someone be sober before an ADHD evaluation?

Practice varies. Waiting several weeks to a few months lets acute and post-acute substance effects clear, which improves diagnostic accuracy. That preference is balanced against the reality that untreated ADHD can be what makes sustained abstinence impossible in the first place. There is no single correct interval, and the decision belongs to the evaluating clinician who knows the individual case.

Can someone in recovery be prescribed stimulant medication for ADHD?

Sometimes, and it depends entirely on the individual situation. A substance use history does not create an automatic permanent disqualification, but it changes the risk assessment and typically adds safeguards such as a single prescriber, prescription monitoring program checks, limited quantities, extended-release or prodrug formulations, urine drug testing, and close coordination with the treatment team. Some programs decline to prescribe stimulants at all, and that is worth asking about before admission.

What are the non-stimulant options for ADHD?

Non-stimulant medications used for ADHD include atomoxetine, viloxazine, extended-release guanfacine and clonidine, and bupropion used off-label. They are not controlled substances and carry minimal misuse liability, which is why they are frequently considered first in someone with active or recent substance use. They generally take weeks to reach full effect and have smaller average effect sizes than stimulants. Which option fits, if any, is a decision for a prescribing clinician.

Will treating ADHD fix the addiction?

No. Treating ADHD can improve the functional capacity that makes recovery work sustainable, including follow-through, appointment attendance, and impulse control, but it does not eliminate cravings or replace addiction treatment. The reverse is also true: getting sober does not resolve ADHD. Both conditions need their own treatment on one coordinated plan.

Which substances do people with ADHD use most often?

Alcohol, cannabis, and nicotine are the most common, with stimulants including cocaine, methamphetamine, and misused prescription stimulants also strongly represented. ADHD raises risk across substance classes rather than pointing at one drug, but the reasons people describe tend to be consistent: sedatives quiet internal restlessness, and stimulants temporarily deliver the focus the person has been chasing.

Is medical detox necessary?

It depends on the substance and the degree of physical dependence, not on the ADHD. Alcohol and benzodiazepine withdrawal can involve seizures and can be fatal without medical management, so supervised detox is not optional for significant dependence on either. Opioid withdrawal is intensely uncomfortable but not usually life-threatening for a stable adult, though medical support improves completion rates and safety. Stimulant and cannabis withdrawal are primarily psychiatric and behavioral. A clinical assessment determines what is needed.

Why do people with ADHD leave detox early?

Detox involves waiting, repetition, unstructured hours, and rules, which is a difficult environment for low frustration tolerance and high novelty seeking. Leaving against medical advice is dangerous during alcohol or benzodiazepine withdrawal and raises overdose risk after opioid detox because tolerance has already dropped. Telling the intake team about a prior early departure lets the program build in more frequent contact, movement, and short-horizon goals.

What is delay discounting and why does it matter here?

Delay discounting is the measurable tendency to value a reward less as the wait for it grows longer. People with ADHD and people with substance use disorders both discount future rewards steeply. It matters because it explains why a genuine commitment can fail two days later without any change of heart, and because it points toward treatments that shorten the gap between behavior and reward, such as contingency management and frequent check-ins.

What does integrated dual diagnosis treatment actually mean?

It means one clinical team treats both conditions on a single coordinated plan, with the prescriber and the counseling staff sharing documentation and decisions. That differs from sequential care, which treats one condition and then the other, and from parallel care, where separate providers work on each condition without routinely communicating. Programs use the dual diagnosis label loosely, so it is worth asking specific questions about psychiatric staffing and coordination.

Can therapy alone help ADHD in recovery?

Behavioral approaches help meaningfully, including cognitive behavioral therapy adapted for adult ADHD, organizational and time-management skills training, contingency management, and dialectical behavior therapy skills for emotional dysregulation. Whether medication is also appropriate is a separate question for a prescriber. Many people benefit from a combination, and behavioral strategies remain useful regardless of what is decided about medication.

What else gets mistaken for ADHD in early recovery?

Post-acute withdrawal, chronic insomnia and untreated sleep disorders, depression, anxiety disorders, PTSD, bipolar disorder, thyroid problems, nutritional deficiencies, head injury, and learning disorders can all produce inattention and restlessness. Several of these commonly coexist with ADHD rather than replacing it as an explanation, which is why a thorough evaluation looks at all of them.

Does an ADHD diagnosis in adulthood require childhood symptoms?

Yes. The DSM-5 requires several symptoms present before age 12, along with impairment in two or more settings. This is the most useful line between ADHD and attention problems caused by substance use, and it is why clinicians ask for school records and for a family member who can describe childhood. Attention problems that began in adulthood after heavy use started are not ADHD, even though they are real.

Are online ADHD screening quizzes reliable?

Screening instruments such as the Adult ADHD Self-Report Scale are useful for flagging who should be evaluated further, but they do not diagnose. They cannot distinguish ADHD from substance effects, sleep deprivation, depression, or anxiety, all of which will produce a positive screen. Treat a positive result as a reason to seek a proper evaluation, not as an answer.

Does insurance cover dual diagnosis treatment in California?

Many plans include behavioral health and substance use treatment benefits, and California has parity protections for mental health and substance use coverage. What is actually covered depends on the specific plan, the level of care requested, network status, and medical necessity criteria. We verify benefits directly with the insurer before anyone commits to anything, and coverage is always verified rather than guaranteed in advance.

Should someone stop their existing ADHD medication before entering treatment?

Not without talking to the prescriber and the admitting program first. Stopping a prescribed medication abruptly on your own is not advisable, and programs differ in whether they continue existing prescriptions. Bring the medication in its original labeled container along with prescriber contact information, and let the intake team coordinate the handoff to their medical staff.

Why is boredom such a big relapse trigger with ADHD?

Understimulation is genuinely aversive for an ADHD brain, and unstructured time carries the highest relapse risk. Recovery plans built entirely around removing things tend to fail. Plans that deliberately add stimulating, structured, legal activity with fast feedback and visible progress tend to hold better, and this is worth building into the plan from the start rather than treating it as an afterthought.

Can Broadway Treatment Center diagnose or treat ADHD?

No. Broadway Treatment Center is a placement and referral service, not a treatment facility, and we do not diagnose, prescribe, or provide clinical care. We help people understand their options, verify insurance benefits, and coordinate admission with independent licensed providers in our network. All diagnosis and treatment is performed by the licensed clinicians at the admitting program.

How do I get help today?

Call (714) 400-2048 at any hour. The conversation is confidential, and it is about understanding the situation and the options rather than committing to anything. If there is immediate danger call 911, and if there is a suicidal or emotional crisis call or text 988. You can also start with insurance verification or reach us through our contact page.

Trusted Sources and Authority References

Editorial Disclaimer

This article was written and reviewed by the Broadway Treatment Center editorial and placement team using current federal and clinical authority sources, including the National Institute of Mental Health, the National Institute on Drug Abuse, SAMHSA treatment improvement protocols, and the American Society of Addiction Medicine. It is provided for general informational purposes only and is not medical advice, a diagnosis, a treatment recommendation, or a substitute for evaluation by a licensed clinician who has met you.

Broadway Treatment Center is a treatment placement and referral service, not a treatment facility. We do not own, operate, or staff any clinic, and we do not diagnose or prescribe. We connect people with a network of verified, licensed independent providers in Orange County and across California, verify insurance benefits, and coordinate admission. Admission to any program depends on a clinical assessment performed by that program, on bed availability, and on insurance authorization. Insurance coverage is verified before any commitment and is never guaranteed in advance. No statement on this page is a promise of a specific clinical outcome, a specific level of coverage, or a specific placement. Decisions about ADHD medication, including any controlled substance, rest entirely with a licensed prescriber. If you are experiencing a medical emergency call 911. If you are in emotional crisis or having thoughts of suicide, call or text 988.